MEDINCELL S.A.
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-06-16
Analyst
RenWrite
Equibles does not estimate personal net worth.
Ram Selvaraju is recorded as Analyst at RenWrite. Ram Selvaraju has spoken on 1 earnings call across 1 company, most recently for MEDINCELL S.A. on June 16, 2026. The companies whose calls Ram Selvaraju spoke on are classified in the Healthcare sector.
“I cannot hear you, but I wanted to ask three quick questions. Firstly, I wanted to know if it would be possible for you to comment on the guidance that Teva has historically been providing regarding UZEDI, which clearly appears very conservative.”
RenWrite
Analyst
Transcript header (unverified)
MEDINCELL S.A.
Biotechnology · Healthcare
Videoconference • Annual results 2025-26
MEDINCELL S.A.